Navigation Links
Queensland- Sunny Side Up Please

A report released by the Australian Institute of Health and Welfare has depicted the somber state of affairs in Queensland. Nearly 20 to 50% of the population is grappling// with depressive symptoms, for which they seem to be relying on anti-depressants heavily.

The situation is so grave, it seems an everyday affair in Queensland where nearly 11,500 prescriptions for anti depressants are handed out to patients.

In 2005-2006 the State’s G.Ps dispensed nearly 4.2 million anti-depressant prescriptions- to the extent that anti -depressant scripts make up for 11% of prescriptions issued in Australia.

Jenny Hargreaves, from the institute's economics and health services group, said, "About 60 per cent of those GP encounters were by females and almost 34 per cent were for depression. Males made up 53.3 per cent of the over 5 million service contacts with public community mental health services and hospital outpatient services and schizophrenia was the most common principal diagnosis reported."

White collar workers were prone to suffer depressive symptoms as compared to rest of the Australians, said another report. A survey conducted among 7500 white collar workers revealed that Lawyers portrayed one of the highest symptoms of depression.

Depression resulted in the loss of productivity among the working population. It is estimated that about 6 million working days were spent unproductively due to depression. The cost of each employee’s absenteeism and loss of productivity due to depression was equated at $9660 annually.

It is well known that depression that goes untreated poses a grave risk for suicide. In 2004, there were 580 cases of suicide reported in Queensland. /
'"/>




Page: 1

Related medicine news :

1. Sunny Side Up - Vitamin-D deficiency linked to Schizophrenia
2. Ticks like Sunny Weather
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Queensland Sunny Side Please

(Date:7/22/2014)... CA (PRWEB) July 22, 2014 As reported ... to a caller request to name her favorite beauty products, ... went on to say that “ Botox has changed ... in the makeup chair preparing for her various, daily appearances. ... eyelashes,” explained Ms. Ripa (see: goo.gl/shmTQM). , “I think that ...
(Date:7/22/2014)... Latin American Conference on Lung Cancer (LALCA 2014) will ... Peru. , Lung Cancer is still the leading cause ... Building on the success of the previous conferences in ... will discuss the science and advances in the treatment ... and Latin America in particular. , With tobacco being ...
(Date:7/22/2014)... 2014 The Entertainment Industries Council, Inc. ... educational tools and recognition activities for thousands of entertainment ... treatment and recovery. On July 24, 2014, at 8pm, ... of these resources with a special mention of the ... treatment website at the end of the show. ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July ... minimally invasive procedure known as morcellation carries a risk of ... likelihood more clearly. Twenty-seven of every 10,000 women who ... of the procedure, researchers found, with the odds being highest ... a hysterectomy with morcellation use a power cutter to slice ...
(Date:7/22/2014)... 22, 2014 5i Sciences, a medical ... appointment of Molly Coye, M.D., M.P.H. to a role ... renowned authority on the market introduction of innovative technologies ... she will advise on strategies for building a successful ... technology. Dr. Coye is currently the Chief Innovation ...
Breaking Medicine News(10 mins):Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2
... multispecialty medical group in Southern California, announced the opening of its ... Monrovia. , ... Torrance, CA (PRWEB) December 16, 2008 ... Southern California, announced the opening of its newest medical office ...
... portal that features the latest news, facts and nutritional updates about ... acai plant and the acai berry fruit to help the general ... ... Dallas, TX (PRWEB) December 16, 2008 -- The announcement ...
... Inc.(CTI),(Nasdaq and MTA: CTIC) announced today they have ... a 50/50 owned joint venture, RIT,Oncology LLC (LLC), ... United States. In connection with the closing, ... and will receive an,additional $7.5 million in early ...
... Dec. 15 Today, the U.S. Food,and Drug Administration ... along with diet to help lower triglycerides,and LDL cholesterol, ... TRILIPIX is the first and only fibrate to ... In certain patients, treatment guidelines,recommend the combination of a ...
... Calif.) -- A secondary analysis of a large, multicenter ... fruits, vegetables and fiber and somewhat lower in fat ... of recurrence in a subgroup of early-stage breast cancer ... by approximately 31 percent. These patients typically have higher ...
... say , , MONDAY, Dec. 15 (HealthDay News) -- Men ... spread beyond the wall of the prostate gland -- ... risk of dying in half, a new study has ... much longer, the Swedish research team concluded. In fact, ...
Cached Medicine News:Health News:HealthCare Partners Opens a New Medical Office in Monrovia, CA 2Health News:AcaiBerryMD.com Explains the Real Facts About the Acai Berry Fruit 2Health News:AcaiBerryMD.com Explains the Real Facts About the Acai Berry Fruit 3Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 2Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 3Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 4Health News:Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US 5Health News:(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:(Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:Diet may cut risk of breast cancer recurrence in women without hot flashes 2Health News:Diet may cut risk of breast cancer recurrence in women without hot flashes 3Health News:Radiation Plus Hormone Therapy Cuts Prostate Cancer Deaths 2Health News:Radiation Plus Hormone Therapy Cuts Prostate Cancer Deaths 3
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
(Date:7/22/2014)... ,  July 22, 2014 The ... Thomson Reuters , the world,s leading provider ... today announced Cortellis Clinical Trials Intelligence ... an industry-first milestone with the documentation of ... pharmaceutical professionals with greater and quicker access ...
(Date:7/22/2014)...  Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. ... with the Icahn School of Medicine at ... ) to utilize its proprietary information and data package ... Niemann-Pick Type C Disease (NPC), a rare disease, mostly ... license also covers other diseases and disorders relying on ...
Breaking Medicine Technology:Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
... is the #1 Pipettor for sub-microliter ... and reliability. Continuously adjustable. Features lPLUS, ... Easy interchangeable ejector buttons to fit ... rapid pipet tip ejector with three ...
... Recommended for aqueous samples of moderate viscosity and density. Proven ergonomic design ... Volume Range(ul) ... 0.8~1.5 Imprecision(%) ... (ul) ...
Medicine Products: